Salesforce (NYSE:CRM) announced a significant partnership with Takeda, selecting its Life Sciences Cloud for customer engagement, which, combined with an expanded partnership with Informatica, ...

Most readers would already be aware that Salesforce's (NYSE:CRM) stock increased significantly by 18% over the ...

Salesforce's growth has decelerated for three straight quarters, with Agentforce yet to deliver on its AI-driven acceleration ...

Salesforce benefits from a first-mover advantage in the thriving AI agent niche. Learn why CRM stock is a Buy.

Salesforce has announced that Vietcombank is implementing Salesforce’s Financial Services Cloud, CRM Analytics, Marketing ...

Salesforce launches Agentforce in Slack, transforming workplace productivity with specialized AI agents that operate as ...

Overall, Wall Street analysts have a consensus “Strong Buy” rating on CRM stock. The average price target of $360.93 implies ...

We recently published a list of Billionaire Mason Morfit’s 10 Stock Picks with Highest Upside Potential. In this article, we ...

We recently published a list of 12 Best Major Stocks to Buy According to Billionaires. In this article, we are going to take ...

Salesforce (NYSE:CRM) recently made headlines with the expansion of its strategic partnership with Informatica, which was ...

The longtime ITSM platform provider believes it can elevate CRM functionality by focusing more on customers, in addition to ...

Takeda joins a growing list of leading pharmaceutical and biotech companies to leverage Life Sciences Cloud for Customer Engagement, a solution designed to unify data and engagement across the entire ...